ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2602

Prevalence of Subclinical Atherosclerosis in Patients with Spondyloarthritis without Clinically Evident Cardiovascular Disease Using Carotid Intima-Media Thickness

Elena Alonso Blanco-Morales1, Carmen Bejerano2, Carlos Fernandez-Lopez3, Natividad Oreiro4, Javier De Toro4, Francisco J. Blanco Garcia3 and Jose A Pinto-Tasende3, 1INIBIC. Complejo Hospitalario Universitario A Coruña, A Coruña, Spain, 2INIBIC, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain, 3Rheumatology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain, 4Rheumatology Department, A Coruña, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose

AS and PsA patients without clinically evident cardiovascular disease have a high prevalence of subclinical cardiovascular disease in form of increased carotid intima-media thickness (IMT) and carotid plaques compared to matched controls.

To evaluate subclinical atherosclerosis by determining carotid IMT and the presence of atheromatous plaques in a sample of patients with PsA and AS, and analyze its relationship with genetic, demographic, clinical and analytical characteristics.

Methods Observational and cross-sectional study of 86 spondyloarthritis patients (48 PsA according CASPAR classification criteria and 38 AS according to the New York modified criteria) were randomly selected from our cohort in 2013. We recorded age and sex of patients, disease duration, joint count, VAS for pain and for global disease activity, BASDAI and BASFI score, ESR, CRP, HLA-B27 and Cw0602, CV risk factors as systolic and diastolic blood pressure, smoking status, glycemia, lipid profile and BMI. IMT (mm) and carotid plaques were measured in the right common carotid artery and the study was performed using high-resolution B-mode ultrasound. Continuous variables were compared using Student’s t-test or Mann-Whitney U test. Proportions were compared by chi-square test or Fisher’s exact test. Correlation between carotid IMT and continuous variables was tested via estimation of Pearson’s partial correlation coefficient adjusted by age at the time of the study. Two-sided P values less than 0.05 were considered to indicate statistical significance. Statistical analysis was performed with the SPSS 17.0 program. It was considered p <0.05 as significant.

Results Carotid IMT was 0.66 (0.16) and correlated with age (rho = 0.444, p< 0.0001), abdominal circumference (r = 0.409, p= 0.001) and CRP level (r = 0.496, p= 0.001). Uveitis and dactylitis were associated with higher IMT (0.74 vs 0.62, p= 0.046; 0.84 vs 0.62, p 0.023). Also high blood pressure was associated with higher IMT (0.73 vs 0.59, p= 0.02). Patients with history for hypertension had higher carotid IMT (p 0.013). All the other variables were not significantly associated with IMT. Patients with PsA had slightly greater carotid artery IMT than AS (0.67 vs 0.60, p = 0.076).

Conclusion In our patients with SAp the carotid intima-media thickness is associated with older age, hypertension, obesity, higher C-reactive protein serum levels, dactylitis and uveitis.


Disclosure:

E. Alonso Blanco-Morales,
None;

C. Bejerano,
None;

C. Fernandez-Lopez,
None;

N. Oreiro,
None;

J. De Toro,
None;

F. J. Blanco Garcia,
None;

J. A. Pinto-Tasende,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-subclinical-atherosclerosis-in-patients-with-spondyloarthritis-without-clinically-evident-cardiovascular-disease-using-carotid-intima-media-thickness/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology